Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lung distribution of inhaled drugs.

× No keyword cloud information.

11 in total

Review 1. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?

Authors: S P Newman
Journal: Br J Clin Pharmacol Date: 2000-06 Impact factor: 4.335

2. Methods to determine lung distribution of inhaled drugs - could gamma scintigraphy be the gold standard?

Authors: H Chrystyn
Journal: Br J Clin Pharmacol Date: 2000-06 Impact factor: 4.335

3. Imaging techniques for assessing drug delivery in man.

Authors:
Journal: Pharm Sci Technolo Today Date: 1999-05

4. Determination of the relative bioavailability of salbutamol to the lung following inhalation.

Authors: M Hindle; H Chrystyn
Journal: Br J Clin Pharmacol Date: 1992-10 Impact factor: 4.335

5. The physico-chemical basis of radiolabelling metered dose inhalers with 99mTc.

Authors: S J Farr
Journal: J Aerosol Med Date: 1996-03

6. Effective dose equivalent.

Authors: R A Shields; R S Lawson
Journal: Nucl Med Commun Date: 1987-11 Impact factor: 1.690

7. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler.

Authors: S Newman; K Steed; G Hooper; A Källén; L Borgström
Journal: Pharm Res Date: 1995-02 Impact factor: 4.200

8. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.

Authors: L Thorsson; S Edsbäcker; T B Conradson
Journal: Eur Respir J Date: 1994-10 Impact factor: 16.671

Review 9. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

Authors: N J Snell; D Ganderton
Journal: Respir Med Date: 1999-02 Impact factor: 3.415

10. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

Authors: M Hindle; D A Newton; H Chrystyn
Journal: Thorax Date: 1993-06 Impact factor: 9.139

3 in total

Review 1. In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors: Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal: AAPS J Date: 2015-05-05 Impact factor: 4.009

2. In vivo tracking and quantification of inhaled aerosol using magnetic particle imaging towards inhaled therapeutic monitoring.

Authors: Zhi Wei Tay; Prashant Chandrasekharan; Xinyi Yedda Zhou; Elaine Yu; Bo Zheng; Steven Conolly
Journal: Theranostics Date: 2018-06-08 Impact factor: 11.556

Review 3. Techniques of assessing small airways dysfunction.

Authors: William McNulty; Omar S Usmani
Journal: Eur Clin Respir J Date: 2014-10-17

3 in total